VijayPD Ceutical IPO
VijayPD Ceutical Limited · Pharmaceutical Distribution
- Issue price
- ₹35per share
- Issue size
- ₹19.25 Cr55,00,000 shares
- Face value
- ₹10per equity share
- Lot size
- 4,000 sharesMin. ₹1.4 L at the upper price
- OpensMon, 2025
- ClosesWed, 2025
- AllotmentFri, 2025
- ListingTue, 2025
Dates marked in the offer document as tentative. Times in IST.
Information only, not investment advice. This page provides information compiled from official offer documents for information purposes only. It is not investment advice or a recommendation to apply for, buy or sell any security. We are not a SEBI-registered investment adviser or research analyst. Investments in IPOs are subject to market risks; read the offer document carefully before investing.
Issue details
- Issue type
- Fixed price, fresh issue
- Fresh issue
- 55,00,000 shares (₹19.25 Cr)
- Offer for sale
- None
- Total issue
- 55,00,000 shares (₹19.25 Cr)
- Market maker portion
- 2,84,000 shares
- Face value
- ₹10
- Listing at
- NSE Emerge
- Promoter holding
- 78.30% → 56.25%
Source: ProspectusUpdated
Reservation
Share of the total issue- Market maker100.0%
| Category | Shares | Of net offer | Stated in RHP |
|---|---|---|---|
| Non-institutional investors (NII) | — | — | — |
| Market maker | 2,84,000 | — | — |
Source: ProspectusUpdated
Lot size
Amounts at ₹35 per share| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail individual investors | 2 | 8,000 | ₹2.8 L |
Source: ProspectusUpdated
Subscription
Category-wise subscription is published by the exchanges while the issue is open. It appears here once the figures are added.
Valuation
FY 2024-25- EPS (basic)
- ₹3.84
- P/E (FY 2024-25 at issue price)
- 9.11×
- RoNW
- 14.91%
- NAV per share
- ₹25.78
Source: ProspectusUpdated
Financials
Consolidated, restated · ₹ crore| Period ended | 31 Mar 2025FY 2024-25 | 31 Mar 2024FY 2023-24 | 31 Mar 2023FY 2022-23 |
|---|---|---|---|
| Revenue from operations | 106.81 | 54.33 | 48.77 |
| Total income | 107.59 | 54.34 | 50.59 |
| EBITDA | 8.59 | 4.87 | 1.32 |
| Profit after tax | 4.80 | 1.65 | 0.18 |
| Net worth | 32.17 | 1.00 | 4.93 |
| Reserves and surplus | 18.14 | — | — |
| Total assets | 57.15 | 33.27 | 32.87 |
| Total borrowing | 21.77 | 30.04 | 25.56 |
FY 2024-25 vs FY 2023-24: revenue +96.6%, profit after tax +190.6%.
Source: ProspectusUpdated
About the company
The company distributes pharmaceutical, wellness and FMCG products to pharmacies, clinics and nursing homes, mainly in Maharashtra. It is also planning to enter manufacturing of APIs and excipients at a proposed plant in MIDC Shrirampur.
- Incorporated
- 2024
- Industry
- Pharmaceutical Distribution
- Sector
- Healthcare and Pharma
- CIN
- U21001MH2024PLC421713
- Website
- vijaypdceutical.com
Source: ProspectusUpdated
Promoters and shareholders
| Name | Type | Before issue | After issue |
|---|---|---|---|
| Vasanti Dhirendra Shah | Promoter | 22.93% | 16.47% |
| Dina Madhukar Shah | Promoter | 11.97% | 8.60% |
| Bhavin Dhirendra Shah | Promoter | 11.66% | 8.38% |
| Narendra Nagindas Shah | Promoter | 11.34% | 8.14% |
| Hemanti Jitendra Shah | Promoter | 7.57% | 5.44% |
| Samit Madhukar Shah | Promoter | 6.29% | 4.52% |
| Rahul Jitendra Shah | Promoter | 0.00% | 0.00% |
| Promoter Group (Jigar Narendra Shah, Kusum Jitendra Shah, Nila Narendra Shah, Chandrika Dilipkumar Shah, Saroj Narendra Shah) | Promoter group | 6.54% | 4.70% |
Source: ProspectusUpdated
Objects of the issue
₹ crore| Purpose | Amount |
|---|---|
| Capital expenditure for API/intermediates and chemicals manufacturing plant and machinery at MIDC Shrirampur | 10.83 |
| Repayment/prepayment of certain borrowings | 5.10 |
| General corporate purposes | 0.74 |
Source: ProspectusUpdated
Peer comparison
As listed in the offer document| Company | EPS | P/E | RoNW | NAV per share |
|---|---|---|---|---|
| Vijaypd Ceutical LimitedIssuer | ₹3.84 | 9.11× | 14.91% | ₹25.78 |
| MedPlus Health Services Limited | ₹3.37 | 249.42× | 3.32% | ₹103.63 |
| Entero Healthcare Solutions Limited | ₹4.41 | 256.17× | 1.17% | ₹379.33 |
Source: ProspectusUpdated
Strengths and risks
Our summary of what the offer document statesStrengths
- Established distribution network serving over 2,000 pharmacies, clinics and nursing homes in Maharashtra and nearby regions.
- Distribution across pharmaceutical, wellness and FMCG product categories with a large SKU range.
- Relationships with more than 170 healthcare product manufacturers.
- Experienced promoter group with long industry tenure.
- Plans to diversify into API and excipient manufacturing.
Risks
- Revenue is entirely concentrated in customers located in Maharashtra.
- No long-term agreements with customers or pharmaceutical manufacturers.
- Company has reported negative operating cash flows in the past.
- Entry into API and excipient manufacturing is a new business with no order book yet.
- Planned plant capex has not yet been ordered and faces delay and cost-overrun risk.
Source: ProspectusUpdated
Documents
Contacts
Source: ProspectusUpdated
Allotment status
Check whether shares were allotted on the official pages below, using your PAN, application number or DP/client ID. Results appear once the basis of allotment is finalised.
- Allotment
- Refunds
- Demat credit
- Listing
Source: ProspectusUpdated
After listing
Listing price, day-one high and low, and the change from the issue price (₹35) appear here after the shares list on NSE Emerge.
Work out the gain or loss on allotted shares after charges and tax →
Frequently asked questions
When does the VijayPD Ceutical IPO open and close?
According to the Prospectus, the issue opens on Monday, 29 September 2025 and closes on Wednesday, 1 October 2025.
What is the VijayPD Ceutical IPO price band?
The final issue price is ₹35 per share.
What is the lot size of the VijayPD Ceutical IPO?
One lot is 4,000 shares, which is ₹1.4 L at ₹35 per share.
Where will VijayPD Ceutical shares list?
On NSE Emerge. The tentative listing date is Tuesday, 7 October 2025.
Who is the registrar of the issue?
KFin Technologies Limited (SEBI registration INR000000221). Allotment status is checked on the registrar's website.
How do I check the VijayPD Ceutical IPO allotment status?
The basis of allotment is expected to be finalised on Friday, 3 October 2025. After that, search by PAN, application number or DP/client ID on the registrar's website (KFin Technologies Limited). Shares that are allotted are credited to your demat account; for an application that is not allotted, the blocked amount is released.
How will the money raised be used?
₹10.83 Cr for capital expenditure for API/intermediates and chemicals manufacturing plant and machinery at MIDC Shrirampur, ₹5.1 Cr for repayment/prepayment of certain borrowings, ₹74.17 L for general corporate purposes.
Related IPOs
More healthcare and pharma IPOs
- Paras Healthcare₹695Listed · 21 Oct – 23 Oct 2026
- Nephrocare Health Services₹438–460Listed · 10 Dec – 12 Dec 2025
- Park Medi World₹162Listed · 10 Dec – 12 Dec 2025
- CORONA Remedies₹1,062Listed · 8 Dec – 10 Dec 2025
Also managed by Smart Horizon Capital Advisors
- Bombay Coated and Special Steels₹82Listed · 29 Oct – 2 Nov 2026
- Pngs Reva Diamond Jewellery₹386Listed · 24 Feb – 26 Feb 2026
- Biopol Chemicals₹108Listed · 6 Feb – 10 Feb 2026
- Pajson Agro IndiaTBAListed · 11 Dec – 15 Dec 2025
Spotted something wrong?
Our data comes from official offer documents, but mistakes can slip through. Report an error and tell us which figure looks wrong and where you saw the correct one (the offer-document page number helps). For anything else, see Contact.